– For the primary composite endpoint, TransCon PTH demonstrated a response rate of 78.7% compared to 4.8% for control . – TransCon PTH demonstrated statistically. | March 13, 2022
– For the primary composite endpoint, TransCon PTH demonstrated a response rate of 78.7% compared to 4.8% for control (p-value <0.0001). – TransCon.
COPENHAGEN, Denmark, Dec. 07, 2021 Ascendis Pharma A/S today announced that the Company will host a virtual R&D Program Update for the investment community on Tuesday, December 14, 2021. . | December 7, 2021
Ascendis Pharma A/S to Host Virtual R&D Program Update on December 14 forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.